{
    "code": 0,
    "data": [
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "1f17125c-2084-4cee-99af-78bf07ea4502",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "news_id": "bcd2daa8-4fbb-422b-b8ab-64a5d9e09cc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "news_id": "8f5027c1-d448-4ffd-965b-6c16a06eeabe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "news_id": "0565c206-6232-408b-88a5-efc6139888b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "news_id": "684c346f-e82f-4bcb-ad81-8f95b8215a9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:51",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "news_id": "4aab579b-2157-4ec8-9893-b220906f0d15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "news_id": "3e2a7da4-1e02-43d7-a772-a531839721b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "news_id": "3139ced0-a554-4e77-8f0f-057bd0c2d406",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "news_id": "1e2a1478-18ed-44cd-a999-e2e160de1d2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "news_id": "945382a7-b56f-4e81-9560-9af3a5c43e7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on January 24 2025.",
            "news_id": "87bd207b-560c-4c83-b1b3-d23e914aaaba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf",
            "news_date": "2025-01-31 14:57:08",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARAPP1",
            "disp": "Solara Active Pharma Sciences - PP",
            "bse_code": 890202,
            "isin": "IN9624Z01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31 2024 and other matters.",
            "news_id": "38d3cdfe-032c-4b86-8c0b-44fa0a030861",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf",
            "news_date": "2025-01-24 14:46:27",
            "seo": "solarapp-ltd",
            "ltp": 334.8,
            "ch": -1.1999999999999886,
            "pch": -0.35714285714285376,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 756939,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}